HCPLive Network

Hyperbaric Oxygen Shows No Benefit for Diabetic Foot Ulcers

THURSDAY, Feb. 28 (HealthDay News) -- For patients with diabetic foot ulcers, use of hyperbaric oxygen (HBO) is not associated with improved healing or with a decrease in the likelihood of amputation, according to a study published online Feb. 19 in Diabetes Care.

David J. Margolis, MD, PhD, from the University of Pennsylvania, in Philadelphia, and colleagues compared the effectiveness of HBO with other conventional therapies in a longitudinal observational cohort study including 6,259 individuals with diabetes, adequate lower limb arterial perfusion, and foot ulcers extending through the dermis.

In propensity score-adjusted models, the researchers found that individuals receiving HBO were significantly less likely to have healing of their foot ulcer (hazard ratio, 0.68) and significantly more likely to have an amputation (hazard ratio, 2.37). HBO was not found to improve the likelihood of wound healing or to reduce the likelihood of amputation in additional analyses including use of an instrumental variable to ascertain the robustness of the results to unmeasured confounding.

"In conclusion, HBO did not appear to be useful for the prevention of amputation and did not improve the likelihood that a wound would heal in a cohort of patients defined by Centers for Medicare and Medicaid Services eligibility criteria," write the authors.

Two authors disclosed financial ties to the National Healing Corp. One of the authors is a consultant to Healogics, which fully owns the National Healing Corporation.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
For patients with type 1 and type 2 diabetes, severe hypoglycemia is associated with severe hypertension, hypokalemia, and QT prolongation.
Ranolazine reduces chest pain in patients with type 2 diabetes and angina, according to a study presented at ACC.13.
Exercise and drug interventions may be similar regarding their effect on mortality in the secondary prevention of coronary heart disease, stroke rehabilitation, and prevention of diabetes, according to research published online Oct. 1 in BMJ.
Intensive glucose-lowering therapy (INT) is associated with favorable changes in lipoprotein levels and inflammatory risk factors even though it does not lower the incidence of cardiovascular events.
Smokers with diabetes have higher smoking quit attempts than smokers without diagnosed diabetes.
For Medicare beneficiaries with congestive heart failure, chronic obstructive pulmonary disease, and type 2 diabetes mellitus, continuity of care is associated with differences in costs, emergency department use, and complications, according to a study published online March 17 in JAMA Internal Medicine.
Obese and overweight patients with dyslipidemia or hypertension treated with phentermine and topiramate extended-release (PHEN/TPM ER) for weight loss had significant improvements in cardiovascular disease risk factors.
More Reading